Bishop JF - Search Results

1

Factors influencing 20-hour increments after platelet transfusion.

Bishop JF, Matthews JP, McGrath K, Yuen K, Wolf MM, Szer J. Bishop JF, et al. Transfusion. 1991 Jun;31(5):392-6. doi: 10.1046/j.1537-2995.1991.31591263191.x. Transfusion. 1991. PMID: 2048176

2

Detection of HLA antibodies by platelet crossmatching techniques.

McGrath K, Holdsworth R, Veale M, Bishop J, Wolf M. McGrath K, et al. Transfusion. 1988 May-Jun;28(3):214-6. doi: 10.1046/j.1537-2995.1988.28388219145.x. Transfusion. 1988. PMID: 3285524

3

Transient platelet and HLA antibody formation in multitransfused patients with malignancy.

McGrath K, Wolf M, Bishop J, Veale M, Ayberk H, Szer J, Cooper I, Whiteside M. McGrath K, et al. Br J Haematol. 1988 Mar;68(3):345-50. doi: 10.1111/j.1365-2141.1988.tb04212.x. Br J Haematol. 1988. PMID: 3355793

4

Clinical factors influencing the efficacy of pooled platelet transfusions.

Bishop JF, McGrath K, Wolf MM, Matthews JP, De Luise T, Holdsworth R, Yuen K, Veale M, Whiteside MG, Cooper IA, et al. Bishop JF, et al. Blood. 1988 Feb;71(2):383-7. Blood. 1988. PMID: 3337903 Free article.

5

The definition of refractoriness to platelet transfusions.

Bishop JF, Matthews JP, Yuen K, McGrath K, Wolf MM, Szer J. Bishop JF, et al. Transfus Med. 1992 Mar;2(1):35-41. doi: 10.1111/j.1365-3148.1992.tb00132.x. Transfus Med. 1992. PMID: 1308461

6

Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients.

Bishop JF, Schiffer CA, Aisner J, Matthews JP, Wiernik PH. Bishop JF, et al. Am J Hematol. 1987 Oct;26(2):147-55. doi: 10.1002/ajh.2830260205. Am J Hematol. 1987. PMID: 3661547

7

The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study Group.

Bishop JF, Matthews JP, Young G, Szer J, Joshua DE, Dodds A, Laidlaw CR, Cobcroft R, Herrman R, Ma D, et al. Bishop JF, et al. Leuk Lymphoma. 1994 Sep;15(1-2):79-84. doi: 10.3109/10428199409051681. Leuk Lymphoma. 1994. PMID: 7858505 Clinical Trial.

8

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, Bradstock K, Enno A, Wolf MM, Fox R, Cobcroft R, Herrmann R, Van Der Weyden M, Lowenthal RM, Page F, Garson OM, Juneja S. Bishop JF, et al. Blood. 1996 Mar 1;87(5):1710-7. Blood. 1996. PMID: 8634416 Free article. Clinical Trial.

9

Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia.

Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, Cobcroft RG, Dodds AJ, Enno A, Gillett EA, Hermann RP, Joshua DE, Ma DD, Szer J, Taylor KM, Wolf M, Bradstock KF; Australian Leukemia Study Group. Matthews JP, et al. Among authors: bishop jf. Br J Haematol. 2001 Jun;113(3):727-36. doi: 10.1046/j.1365-2141.2001.02756.x. Br J Haematol. 2001. PMID: 11380464 Free article.

10

A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.

Bishop JF, Matthews JP, Wolf MM, Oliver IN, Reynolds S, Walpole E, Rischin D, Buchanan L, Tan LG. Bishop JF, et al. Eur J Cancer. 1992;28(1):47-50. doi: 10.1016/0959-8049(92)90382-c. Eur J Cancer. 1992. PMID: 1567690 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters